Literature DB >> 2394445

DNA sequence analysis of the KM19 locus linked to cystic fibrosis. Design of new oligonucleotides to remove non-specific PCR products.

R Anwar1, K Murray, P J Hedge, J C Smith, A F Markham.   

Abstract

The PstI polymorphism detected by probe KM19 is a highly informative marker in linkage disequilibrium with the cystic fibrosis locus and has been used extensively for prenatal diagnosis. The currently available primers used for polymerase chain reaction- (PCR-) based analysis of this locus have been shown to produce spurious amplification products. In this report, we describe the sequence of the KM19 locus and the major contaminating PCR product. We have used this information to design a more specific amplification procedure for analysis of the KM19 locus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394445     DOI: 10.1007/bf00206754

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences.

Authors:  T Triglia; M G Peterson; D J Kemp
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

2.  Experience with new DNA markers for the diagnosis of cystic fibrosis.

Authors:  A L Beaudet; J E Spence; M Montes; W E O'Brien; X Estivill; M Farrall; R Williamson
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

3.  Sequence analysis of the human major histocompatibility gene SX alpha.

Authors:  J M Boss; R Mengler; K Okada; C Auffray; J L Strominger
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

4.  Patterns of polymorphism and linkage disequilibrium for cystic fibrosis.

Authors:  X Estivill; P J Scambler; B J Wainwright; K Hawley; P Frederick; M Schwartz; M Baiget; J Kere; R Williamson; M Farrall
Journal:  Genomics       Date:  1987-11       Impact factor: 5.736

5.  Genetic linkage map of human chromosome 7 with 63 DNA markers.

Authors:  D Barker; P Green; R Knowlton; J Schumm; E Lander; A Oliphant; H Willard; G Akots; V Brown; T Gravius
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Diagnosis of alpha 1-antitrypsin deficiency by enzymatic amplification of human genomic DNA and direct sequencing of polymerase chain reaction products.

Authors:  C R Newton; N Kalsheker; A Graham; S Powell; A Gammack; J Riley; A F Markham
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker.

Authors:  L C Tsui; M Buchwald; D Barker; J C Braman; R Knowlton; J W Schumm; H Eiberg; J Mohr; D Kennedy; N Plavsic
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

10.  Localization of cystic fibrosis locus to human chromosome 7cen-q22.

Authors:  B J Wainwright; P J Scambler; J Schmidtke; E A Watson; H Y Law; M Farrall; H J Cooke; H Eiberg; R Williamson
Journal:  Nature       Date:  1985 Nov 28-Dec 4       Impact factor: 49.962

View more
  2 in total

1.  Cystic fibrosis in the Basque country: high frequency of mutation delta F508 in patients of Basque origin.

Authors:  T Casals; C Vázquez; C Lázaro; E Girbau; F J Giménez; X Estivill
Journal:  Am J Hum Genet       Date:  1992-02       Impact factor: 11.025

2.  Mutation and linkage disequilibrium analysis in genetic counselling of Spanish cystic fibrosis families.

Authors:  T Casals; V Nunes; C Lázaro; F J Giménez; E Girbau; V Volpini; X Estivill
Journal:  J Med Genet       Date:  1991-11       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.